Latest News

US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell




MONTPELLIER, France–(BUSINESS WIRE)–Euronext: MEDCL “Clinical development will become a significant part of MedinCell’s expenses and will define the time to market of our products. Bringing on board Richard, with his wealth of knowledge in pharmaceutical development, clinical trial strategy and design optimization will be instrumental to our performance,” states Christophe Douat, CEO of MedinCell. To access the complete version of the press release, visit https://invest.medincell.com/#news Ab

Source link





Related posts

BD preps Arizona relo for peripheral interventions biz, expands in Ireland

Newsemia

Medical News Today: Causes and treatments for bumps on the gums

Newsemia

Younger colorectal cancer patients experience delays in care leading to emergency diagnoses

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy